Evaluation of Helicobacter species in inflammatory bowel disease
- PMID: 12950420
- DOI: 10.1046/j.1365-2036.2003.01703.x
Evaluation of Helicobacter species in inflammatory bowel disease
Abstract
Background: Bacteria have been implicated in the pathogenesis of inflammatory bowel disease. Helicobacter species have been shown to cause colitis in animal models and have been identified in human diarrhoeal illness and Crohn's disease.
Aim: To determine whether Helicobacter species are present in human inflammatory bowel disease tissue.
Methods: Thirty patients undergoing colonoscopy for clinical reasons were studied. Nine had Crohn's disease, 11 had ulcerative colitis and 10 had histologically normal colons. Tissue was snap-frozen at -70 degrees C. DNA was extracted and examined by five different polymerase chain reaction (PCR) assays that were either genus or species specific for Helicobacter.
Results: Analyses of colonic biopsies by two Helicobacter genus-specific PCR assays, two H. pylori-specific assays and a PCR assay designed to amplify fragments of 'H. heilmannii'-like organisms demonstrated that product was not generated by any test. Internal control PCR demonstrated that PCR results for the five assays were not negative due to the presence of residual substances inhibitory to PCR.
Conclusions: Helicobacter species were not identified in this study, using multiple PCRs to eliminate the problems of non-specific cross-reaction. This suggests that Helicobacter species do not play a role in the pathogenesis of inflammatory bowel disease.
Comment in
-
Helicobacter species in human colon biopsies.Aliment Pharmacol Ther. 2004 Mar 1;19(5):613-4. doi: 10.1111/j.1365-2036.2004.01880.x. Aliment Pharmacol Ther. 2004. PMID: 14987330 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical